Reimer J M B, Deodatus J A, Nguyen T K M, den Hertog M H
Isala, afd. Neurologie, Zwolle.
Contact: J. M.B. Reimer (
Ned Tijdschr Geneeskd. 2021 Feb 18;165:D5337.
Cerebral amyloid angiopathy (CAA) is a degenerative neurovascular disease in which the protein amyloid-beta accumulates in the vessel wall of cortical and leptomeningeal arteries. This may lead to acute lobar cerebral haemorrhage, which in case of CAA is fatal in 10-30% of cases. CAA may also present with transient focal neurological episodes (TFNE), the symptoms of which may mimic a transient ischaemic attack (TIA). Distinction between the two has important implications for therapy, as antithrombotics are relatively contra-indicated in CAA, but indicated after a TIA. We describe a patient with transient focal neurological deficits who was initially treated with antithrombotic therapy for a suspected TIA. Eventually, the diagnosis CAA was made and antithrombotic treatment was ceased. This case stresses the importance of considering the diagnosis CAA with TFNE in patients presenting with transient neurological deficits, in order to avoid an unnecessarily increased risk of symptomatic and possibly fatal cerebral haemorrhage.
脑淀粉样血管病(CAA)是一种退行性神经血管疾病,其中β淀粉样蛋白在皮质和软脑膜动脉的血管壁中积聚。这可能导致急性脑叶脑出血,在CAA患者中,10%-30%的病例会因此致命。CAA也可能表现为短暂性局灶性神经发作(TFNE),其症状可能类似于短暂性脑缺血发作(TIA)。区分两者对治疗具有重要意义,因为抗血栓药物在CAA中相对禁忌,但在TIA后则有使用指征。我们描述了一名有短暂性局灶性神经功能缺损的患者,最初因疑似TIA接受了抗血栓治疗。最终,确诊为CAA并停止了抗血栓治疗。该病例强调了在出现短暂性神经功能缺损的患者中考虑CAA伴TFNE诊断的重要性,以避免不必要地增加有症状且可能致命的脑出血风险。